Nu N. Le
6 Papers
Nu N. Le is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy
Wen Li,Nu N. Le,Natsuko Onishi,David C. Newitt,Lisa J. Wilmes,Jessica Gibbs,Julia C. Carmona-Bozo,Jiachao Liang,Savannah C. Partridge,Elissa R. Price,Bonnie N. Joe,John Kornak,Mark Jesus M. Magbanua,Rita Nanda,B. Lestage,Laura J. Esserman,I-Spy Imaging Working Group,I-Spy Investigator Network,Laura J. van't Veer,Nola M. Hylton +19 more
TL;DR: It is found diffusion-weighted MRI is superior to dynamic contrast-enhanced MRI, where the latter is a standard and most-commonly used MRI modality, in assessing immunotherapy, while no significant difference was observed in the control cohort where only standard chemotherapy was provided.
15
Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer
Nu N. Le,Wen Li,Natsuko Onishi,David C. Newitt,Jessica Gibbs,Lisa J. Wilmes,John Kornak,Savannah C. Partridge,B. Lestage,Elissa R. Price,Bonnie N. Joe,Laura J. Esserman,Nola M. Hylton +12 more
TL;DR:
Abstract P3-03-02: Diffusion-weighted MRI for prediction of pathologic complete response in HER2- breast cancer treated with pembrolizumab plus neoadjuvant chemotherapy
Wen Li,Nu N. Le,Natsuko Onishi,David C. Newitt,Jessica Gibbs,Lisa J. Wilmes,John Kornak,Savannah C. Partridge,B. Lestage,Elissa R. Price,Bonnie N. Joe,Laura J. Esserman,Nola M. Hylton +12 more
TL;DR: Tumor ADC, measured using diffusion-weighted MRI, demonstrates potential as a biomarker for assessing early response to immunotherapy in the neoadjuvant setting for high risk HER2- breast cancer.
Abstract P6-01-33: Diffusion-weighted magnetic resonance imaging for subtype-specific prediction of pathologic complete response in neoadjuvant chemotherapy
Judith Zimmermann,Julia C. Carmona-Bozo,Nu N. Le,Natsuko Onishi,Lisa J. Wilmes,Jessica Gibbs,Jiachao Liang,David C. Newitt,Savannah C. Partridge,Patrick J. Bolan,Bonnie N. Joe,Elissa R. Price,B. Lestage,Nola M. Hylton,Wen Li +14 more
TL;DR: A group of histogram-based ADC metrics in addition to mean ADC are compared for early prediction of pCR in patients stratified by breast cancer subtype and the predictive power of ADC metrics and FTV is compared.
Abstract PD16-07: Association of MRI morphologic phenotype from unsupervised learning with breast cancer subtypes and treatment response
Nu N. Le,Natsuko Onishi,David C. Newitt,Jessica Gibbs,Lisa J. Wilmes,Efstathios D. Gennatas,B. Lestage,Laura J. Esserman,Nola M. Hylton,Wen Li +9 more
TL;DR: Lee et al. as mentioned in this paper investigated if MRI morphologic phenotypes defined by unsupervised clustering is associated with breast cancer subtype and pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC).